Design Therapeutics, Inc. · NASDAQ:DSGN

Point72 Asset Management, L.P. reported a 5.10% stake in Design Therapeutics, Inc. (Schedule 13G)

Event Jun 8, 2026 · Filed Jun 9, 2026

Point72 Asset Management, L.P. reported a 5.10% stake in Design Therapeutics, Inc., 3,197,764 shares, as a passive investor on Jun 8, 2026. Filed Jun 9, 2026 (Schedule 13G).

Stake
5.10%
Shares
3,197,764
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.5.10%3,197,764
Point72 Capital Advisors, Inc.5.10%3,197,764
Steven A. Cohen5.10%3,197,764

Source

View original at SEC

Related